Jun 06, 2023 / 12:00PM GMT
Timothy Power - Bristol-Myers Squibb Company - VP & Head of IR
Good morning. This is Tim Power from the Bristol-Myers Group Investor Relations. Welcome to our investor event at ASCO 2023. We're presenting important data across our hematology and oncology portfolios this week. So it's exciting news for patients and lots to discuss today.
I'm joined for today's discussion by Samit Hirawat, our Chief Medical Officer; and by Adam Lenkowsky, our Chief Commercialization Officer. Samit and Adam will go through our slide presentation followed by Q&A at the end. And also be joined by 2 of our cell therapy leaders, Lynelle Hoch, Senior Vice President, Cell Therapy Franchise Lead; and Rosanna Ricafort, Vice President, Cell Therapy Clinical Development Lead.
We'll go to Slide 2 and on this slide, I'll refer you to our forward-looking statements. And with that, I'll hand over to Samit to begin the presentation on the slide.
Samit Hirawat - Bristol-Myers Squibb Company - Executive VP & Chief Medical Officer of Drug Development
Thank you, Tim.
Bristol-Myers Squibb Co Virtual Investor Event: ASCO 2023 Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers